CURRICULUM VITAE
Tamara Margana
Born on Gigliames
Citizen of Augariana & United Kingdom
Birth date 01/01/1973
Height 6" (1.83 m)
Weight 156 lbs (71 kg)
Eye Brown
Hair Brown
Professor, Psychopharmacology and Neurodevelopment, McLaren Non-Performance Academy, Woking, Surrey, England / United Kingdom, 2022
PhD, Psychopharmaco-Engineering, University of Ganarda Sagradia, Barcelona, Catalonia, 2021
Fellowship of Global Neurodevelopment Expert Working Group, since 2017
Fellowship of Global Truth Causes, since 2016
PhD (honoris causa), Neurodevelopment and Neuroembryology, University of Aldridge-Hall-Albright, Nottingham, England / United Kingdom, class of 2015
Fellowship of Global Delta-Alpha-Omega - Psychopharmacology, since 2012
Master of Science, Psychopharmacology, University of Aldridge-Hall-Albright, Nottingham, England / United Kingdom, class of 2009
Bachelor of Science, Biotechnology-Biomedicine + Medical Engineering (double-degree), University of Aldridge-Hall-Albright, Nottingham, England / United Kingdom, class of 1996
Veritaject and Veritasensor Project, Committee Chief, 2034-current
Faculty of Biotechnology-Biomedicine, University of Aldridge-Hall-Albright, Nottingham, England / United Kingdom, head assistant, 2015-2030
Faculty of Biotechnology-Biomedicine, Ralmified-Somberstone Institute of Technology, Augariana, Dean, 2031-2040
Dopa-Ark-Syn-kinase Inhibitor [Veritaject]: The Future of Our Telling-Truth Community? Intern Pharmacol Rev. 2048; 116 (5): 1257-70
Dopa-Ark-Syn-kinase Inhibitor [Veritaject]: Pharmacological Overview. Intern Pharmacol Rev. 2047; 115 (12): 3624-41
Connection between Brain Higher Function, Cognitive Behaviors, and Release of Dopa-Ark-Syn-kinase Level of Gray Matter of Cerebrum, J Analytic Neurodev Res. 2045; 31(Nov): 10425-37
Brain Higher Function Activity during High-Peak Stimulation of Dopa-Ark-Syn-kinase Production Regardless Dopamine Intake, J Intern Neurodev Psychopharmacol. 2044; 56 (11): 341-8
Correlation between Cognitive Behaviors and Dopa-Ark-Syn-kinase Inhibitor Administration Route: Study Case Analysis on Intravenous or Intradermal or Subcutaneous or Oral Intake, Glob Neurodev Psycopharmacol Paraphernal J. 2041; 11 (1): 35-52
Dopa-Ark-Syn-kinase Inhibitor. Intern Drug Analyt Progress 2038, 29 (4): 41-70
Kembalilah ke bab tempat kamu menemukan dokumen ini.
KAMU SEDANG MEMBACA
Conundrum Apropos
Science Fiction**The Watty's Award 2020 Winner: Science Fiction in Indonesian** **Cerita pilih-sendiri-petualanganmu** Negaramu, Augariana, lelah menghadapi kebohongan penduduknya, baik bohong putih maupun hitam. Wacana "Jujur Konsisten Lurus" mulai dicanangkan, d...
